These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22191590)

  • 1. 40th anniversary Drug Metabolism Discussion Group Open Meeting.
    Brady K;
    Bioanalysis; 2012 Jan; 4(1):13-5. PubMed ID: 22191590
    [No Abstract]   [Full Text] [Related]  

  • 2. A tiered approach to address regulatory drug metabolite-related issues in drug development.
    Ma S; Chowdhury SK
    Bioanalysis; 2014 Mar; 6(5):587-90. PubMed ID: 24620798
    [No Abstract]   [Full Text] [Related]  

  • 3. Free versus total ligand-binding assays: points to consider in biotherapeutic drug development.
    Yang J; Quarmby V
    Bioanalysis; 2011 Jun; 3(11):1163-5. PubMed ID: 21649490
    [No Abstract]   [Full Text] [Related]  

  • 4. Mass spectrometry imaging in drug development.
    Nilsson A; Goodwin RJ; Shariatgorji M; Vallianatou T; Webborn PJ; Andrén PE
    Anal Chem; 2015 Feb; 87(3):1437-55. PubMed ID: 25526173
    [No Abstract]   [Full Text] [Related]  

  • 5. A reflection on fit-for-purpose metabolite investigation at different stages of drug development.
    Leclercq L
    Bioanalysis; 2014 Mar; 6(5):591-4. PubMed ID: 24620799
    [No Abstract]   [Full Text] [Related]  

  • 6. Tiered approach to metabolite quantification: regional practices reviewed by Japan Bioanalysis Forum discussion group.
    Niwa M; Uchimura T; Koseki N; Satsukawa M; Hashimoto Y; Mayumi T; Yasuda Y; Yokoi H
    Bioanalysis; 2015; 7(8):935-8. PubMed ID: 25966006
    [No Abstract]   [Full Text] [Related]  

  • 7. Conference report: Inaugural Applied Pharmaceutical Analysis: India 2010 conference.
    Ramanathan R; Chaudhary A
    Bioanalysis; 2010 Jul; 2(7):1181-4. PubMed ID: 21083232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitigating heterocycle metabolism in drug discovery.
    St Jean DJ; Fotsch C
    J Med Chem; 2012 Jul; 55(13):6002-20. PubMed ID: 22533875
    [No Abstract]   [Full Text] [Related]  

  • 9. High-resolution mass spectrometry will dramatically change our drug-discovery bioanalysis procedures.
    Korfmacher W
    Bioanalysis; 2011 Jun; 3(11):1169-71. PubMed ID: 21649491
    [No Abstract]   [Full Text] [Related]  

  • 10. Conference report: summary of the 2010 Applied Pharmaceutical Analysis Conference.
    Unger SE
    Bioanalysis; 2011 Jan; 3(1):11-5. PubMed ID: 21175361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of HT-ADME in drug discovery.
    Morgan D
    Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy.
    Obach RS
    Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
    Yu XQ; Wilson AG
    Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
    [No Abstract]   [Full Text] [Related]  

  • 14. Meeting the demands of regulatory requirements: the significance of ADME.
    Guttendorf R
    Bioanalysis; 2012 Jun; 4(12):1395-7. PubMed ID: 22793021
    [No Abstract]   [Full Text] [Related]  

  • 15. Technologies and strategies to characterize and quantitate metabolites in drug discovery and development.
    Ravindran S; Jadhav A; Surve P; Lonsane G; Honrao P; Nanda B
    Biomed Chromatogr; 2014 Nov; 28(11):1547-53. PubMed ID: 25175001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of endogenous roles of transporters for drug discovery: hitchhiking and metabolite-likeness.
    Kell DB
    Nat Rev Drug Discov; 2016 Feb; 15(2):143. PubMed ID: 26837595
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytochrome P450 metabolism and inhibition: analysis for drug discovery.
    Jones BC; Middleton DS; Youdim K
    Prog Med Chem; 2009; 47():239-63. PubMed ID: 19328293
    [No Abstract]   [Full Text] [Related]  

  • 18. Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery.
    Naritomi Y; Sanoh S; Ohta S
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):31-39. PubMed ID: 29183653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RESOLUTE consortium: unlocking SLC transporters for drug discovery.
    Superti-Furga G; Lackner D; Wiedmer T; Ingles-Prieto A; Barbosa B; Girardi E; Goldmann U; Gürtl B; Klavins K; Klimek C; Lindinger S; Liñeiro-Retes E; Müller AC; Onstein S; Redinger G; Reil D; Sedlyarov V; Wolf G; Crawford M; Everley R; Hepworth D; Liu S; Noell S; Piotrowski M; Stanton R; Zhang H; Corallino S; Faedo A; Insidioso M; Maresca G; Redaelli L; Sassone F; Scarabottolo L; Stucchi M; Tarroni P; Tremolada S; Batoulis H; Becker A; Bender E; Chang YN; Ehrmann A; Müller-Fahrnow A; Pütter V; Zindel D; Hamilton B; Lenter M; Santacruz D; Viollet C; Whitehurst C; Johnsson K; Leippe P; Baumgarten B; Chang L; Ibig Y; Pfeifer M; Reinhardt J; Schönbett J; Selzer P; Seuwen K; Bettembourg C; Biton B; Czech J; de Foucauld H; Didier M; Licher T; Mikol V; Pommereau A; Puech F; Yaligara V; Edwards A; Bongers BJ; Heitman LH; IJzerman AP; Sijben HJ; van Westen GJP; Grixti J; Kell DB; Mughal F; Swainston N; Wright-Muelas M; Bohstedt T; Burgess-Brown N; Carpenter L; Dürr K; Hansen J; Scacioc A; Banci G; Colas C; Digles D; Ecker G; Füzi B; Gamsjäger V; Grandits M; Martini R; Troger F; Altermatt P; Doucerain C; Dürrenberger F; Manolova V; Steck AL; Sundström H; Wilhelm M; Steppan CM
    Nat Rev Drug Discov; 2020 Jul; 19(7):429-430. PubMed ID: 32265506
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue analysis - a powerful tool for drug discovery and development.
    Ho S
    Bioanalysis; 2012 Nov; 4(21):2545-7. PubMed ID: 23173788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.